Acquire rights to innovative therapeutics and technologies
Monetize your IP and product portfolios globally
Build cross-border alliances in pharma and biotech
Spin off assets into new independent entities
Looking for hidden opportunities in global pharma? Our insights reveal them.
December 23, 2025
A technical analysis of valuation multiples and integration savings in the consolidation wave.
December 22, 2025
Transforming the BD function from a transactional support role into a core scientific strategy engine.
December 21, 2025
Navigating the world's second-largest market: From NMPA acceleration to the ADC licensing surge.
December 20, 2025
A definitive guide to biopharma asset-centric company formation and venture strategy.
December 19, 2025
A strategic framework for cross-border asset acquisition, monetization, and partnership structuring.
